DK1296651T3 - Process for preparation of particles for use in a pharmaceutical composition - Google Patents

Process for preparation of particles for use in a pharmaceutical composition

Info

Publication number
DK1296651T3
DK1296651T3 DK01947612T DK01947612T DK1296651T3 DK 1296651 T3 DK1296651 T3 DK 1296651T3 DK 01947612 T DK01947612 T DK 01947612T DK 01947612 T DK01947612 T DK 01947612T DK 1296651 T3 DK1296651 T3 DK 1296651T3
Authority
DK
Denmark
Prior art keywords
particles
preparation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DK01947612T
Other languages
Danish (da)
Inventor
David Alexander Vodden Morton
John Nicholas Staniforth
Rosella Musa
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0029263A external-priority patent/GB0029263D0/en
Priority claimed from PCT/GB2001/001732 external-priority patent/WO2001078694A2/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority claimed from PCT/GB2001/002860 external-priority patent/WO2002000197A1/en
Application granted granted Critical
Publication of DK1296651T3 publication Critical patent/DK1296651T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01947612T 2000-06-27 2001-06-27 Process for preparation of particles for use in a pharmaceutical composition DK1296651T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00113608 2000-06-27
GB0029263A GB0029263D0 (en) 2000-11-30 2000-11-30 Method of making particles for use in a pharmaceutical composition
PCT/GB2001/001732 WO2001078694A2 (en) 2000-04-17 2001-04-17 Formulations for use in inhaler devices
PCT/GB2001/002860 WO2002000197A1 (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK1296651T3 true DK1296651T3 (en) 2008-02-11

Family

ID=27223055

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01947612T DK1296651T3 (en) 2000-06-27 2001-06-27 Process for preparation of particles for use in a pharmaceutical composition

Country Status (5)

Country Link
JP (1) JP5698423B2 (en)
AU (2) AU6926101A (en)
CA (1) CA2413692C (en)
DE (1) DE60131399T3 (en)
DK (1) DK1296651T3 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1849830B1 (en) * 2005-01-28 2012-02-29 Takeda Pharmaceutical Company Limited Finely divided composition containing poorly water soluble substance
ITMI20051999A1 (en) * 2005-10-21 2007-04-22 Eratech S R L INHALATION FORMULATIONS OF DRUGS IN DRY POWDER FOR ADMINISTRATION AS SUCH OR WITH NEBULIZER AND EQUIPPED WITH HIGH EROGABILITY RESPIRABILITY AND STABILITY
NO2560611T3 (en) * 2010-04-21 2018-06-02
EP2836204B1 (en) * 2012-04-13 2020-07-08 GlaxoSmithKline Intellectual Property Development Limited Aggregate particles
ES2867552T3 (en) * 2013-07-11 2021-10-20 Chiesi Farm Spa Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta adrenergic for administration by inhalation
MA40910A (en) * 2014-11-07 2017-09-12 Civitas Therapeutics Inc RAPAMYCIN POWDERS FOR PULMONARY ADMINISTRATION
WO2019009335A1 (en) * 2017-07-04 2019-01-10 村上　正裕 Method for producing fine particles, and fine particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204826B (en) * 1986-03-04 1989-03-10 Chiesi Farma Spa INHALATION PHARMACEUTICAL COMPOSITIONS
SE8603812D0 (en) * 1986-09-12 1986-09-12 Draco Ab ADMINISTRATION OF LIPOSOMES TO MAMMALS
DE3917617A1 (en) * 1989-05-31 1990-12-06 Boehringer Ingelheim Kg MICRONIZED BIODEGRADABLE PARTICLES, PROCESS FOR THEIR PREPARATION AND THEIR USE
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
WO1998031346A1 (en) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation of particles for inhalation
DK2198858T3 (en) * 1998-03-26 2011-10-03 Astellas Pharma Inc Sustained release preparation of a macrolide compound such as tacrolimus
CZ303154B6 (en) * 1998-11-13 2012-05-09 Jagotec Ag Dry powder formulation for inhalation containing magnesium stearate
GB9826783D0 (en) * 1998-12-04 1999-01-27 Scherer Ltd R P Inhalation powders
GB9827145D0 (en) * 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders

Also Published As

Publication number Publication date
AU2001269261B2 (en) 2005-11-17
JP2004501183A (en) 2004-01-15
DE60131399T3 (en) 2019-11-14
AU6926101A (en) 2002-01-08
JP5698423B2 (en) 2015-04-08
CA2413692C (en) 2011-10-18
DE60131399T2 (en) 2008-04-17
CA2413692A1 (en) 2002-01-03
DE60131399D1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
DK1296656T3 (en) Process for the preparation of a composition
AU2211502A (en) Method of making particles for use in a pharmaceutical composition
DK1158992T3 (en) Use of xenon for the preparation of a pharmaceutical composition for the treatment of neurointoxins
ATE279961T1 (en) NEW PHARMACEUTICAL COMPOSITION
EE05378B1 (en) Use of soluble ÁCTLA4AFusion molecule for the preparation of a pharmaceutical composition
ATE355271T1 (en) PHARMACEUTICAL COMPOSITION
ATE404180T1 (en) FLAVOR-MASKED PHARMACEUTICAL PARTICLES
DK1326585T3 (en) Process for the preparation of powder formulations
DK1349580T4 (en) Process for improving the stability of a pharmaceutical composition
NO20025450L (en) New pharmaceutical composition
ATE320244T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AMLODIPINMALEATE
FI20001749A0 (en) Pharmaceutical compositions
DK1309545T3 (en) Process for the preparation of alkylarylsulfonates
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
DE60318167D1 (en) Pharmaceutical form and process for its preparation
HUP0300539A3 (en) New pharmaceutical composition in form of emulsion preconcentrate
ATE366128T1 (en) PHARMACEUTICAL COMPOSITION
DK1296651T3 (en) Process for preparation of particles for use in a pharmaceutical composition
ATE350016T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BICALUTAMID
DK1326836T3 (en) Process for Preparation of 3-Amino-2-chloro-4-methylpyridine
ATE222586T1 (en) BENZENESULFONAMIDE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
NO20030156L (en) Pharmaceutical compositions and methods for their use
DK1171444T3 (en) Pyridothienodiazepines, process for their preparation and pharmaceutical compositions containing them
IL153897A0 (en) Pharmaceutical compositions and methods for use
ATE350029T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GAMMA-BUTYROBETAIN